Strategic Alliances and the Boundaries of the Firm

Strategic alliances are long-term contracts between legally distinct organizations that provide for sharing the costs and benefits of a mutually beneficial activity. In this paper, I develop and test a model that helps explain why firms sometimes prefer alliances over internally organized projects. I introduce managerial effort into a model of internal capital markets and show how strategic alliances help overcome incentive problems that arise when headquarters cannot pre-commit to particular capital allocations. The model generates a number of implications, which I test using a large sample of alliance transactions in conjunction with Compustat data.

[1]  Josh Lerner,et al.  Ownership and Control Rights in Internet Portal Alliances, 1995-1999 , 2003 .

[2]  P. Fulghieri,et al.  The Ownership and Financing of Innovation in R&D Races , 2001 .

[3]  D. Mowery,et al.  Strategic alliances and interfirm knowledge transfer , 1996 .

[4]  Sandro Brusco,et al.  Reallocation of Corporate Resources and Managerial Incentives in Internal Capital Markets , 2000, SSRN Electronic Journal.

[5]  Toby E. Stuart,et al.  Network Eects in the Governance of Biotech Strategic Alliances , 2002 .

[6]  S. Lenway,et al.  Cooperative Strategies in International Business , 1988 .

[7]  Jeffrey W. Allen,et al.  Corporate Equity Ownership, Strategic Alliances and Product Market Relationships , 1999 .

[8]  Toby E. Stuart,et al.  Financial Contracting in Biotech Strategic Alliances , 2002, The Journal of Law and Economics.

[9]  J. Tirole,et al.  Formal and Real Authority in Organizations , 1997, Journal of Political Economy.

[10]  D. Scharfstein,et al.  The Dark Side of Internal Capital Markets: Divisional Rent-Seeking and Inefficient Investment , 1997 .

[11]  O. Hart,et al.  Property Rights and the Nature of the Firm , 1988, Journal of Political Economy.

[12]  John J. McConnell,et al.  Corporate Combinations and Common Stock Returns: The Case of Joint Ventures , 1985 .

[13]  Sanford J. Grossman,et al.  The Costs and Benefits of Ownership: A Theory of Vertical and Lateral Integration , 1986 .

[14]  Henri Servaes,et al.  The Cost of Diversity : The Diversification Discount and Inefficient Investment , 1997 .

[15]  Mark B. Houston,et al.  A Rexamination of the Motives and Gains in Joint Ventures , 2000, Journal of Financial and Quantitative Analysis.

[16]  Derek Oler,et al.  What's My Line? A Comparison of Industry Classification Schemes for Capital Market Research , 2003 .

[17]  O. Williamson,et al.  The mechanisms of governance , 1996 .

[18]  Roger G. Ibbotson,et al.  THE MARKET'S PROBLEMS WITH THE PRICING OF INITIAL PUBLIC OFFERINGS , 1994 .

[19]  S. Viswanathan,et al.  Market Valuation and Merger Waves , 2004 .

[20]  J. Stein,et al.  Information Production and Capital Allocation: Decentralized vs. Hierarchical Firms , 2000 .

[21]  Arthur J. Keown,et al.  Do strategic alliances create value , 1997 .

[22]  Daniel A. Levinthal,et al.  ABSORPTIVE CAPACITY: A NEW PERSPECTIVE ON LEARNING AND INNOVATION , 1990 .

[23]  David H. Hsu,et al.  When Does Start-Up Innovation Spur the Gale of Creative Destruction? , 2000 .

[24]  R. Merges,et al.  The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry , 2003 .

[25]  Richmond Mathews.  Strategic Alliances, Equity Stakes, and Entry Deterrence , 2005 .

[26]  Thomas J. Chemmanur,et al.  Why Issue Tracking Stock? Insights from a Comparison with Spin-Offs and Carve-Outs , 2000 .

[27]  R. Merges,et al.  The Control of Strategic Alliances: An Empirical Analysis of Biotechnology Collaborations , 1997 .

[28]  J. Stein,et al.  Internal Capital Markets and the Competition for Corporate Resources , 1995 .

[29]  A. Gambardella.  Competitive advantages from in-house scientific research: The US pharmaceutical industry in the 1980s * , 1992 .

[30]  Massimo G. Colombo,et al.  Agreements between firms and the technological life cycle model: Evidence from information technologies , 1992 .

[31]  Josh Lerner,et al.  Do Equity Financing Cycles Matter?: Evidence from Biotechnology Alliances , 1999 .